Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -57.13%38.78M | -65.73%32.79M | -88.70%24.19M | 126.09%493.41M | 109.68%140.01M | 40.31%90.48M | 125.80%95.68M | 379.77%214.02M | 18.89%218.24M | -24.08%66.77M |
| Cost of revenue | -47.23%41.94M | -68.08%25.63M | -93.53%12.29M | 211.73%416.8M | 213.15%109.94M | 74.93%79.49M | 227.94%80.28M | 561.80%189.78M | 0.27%133.7M | -46.25%35.11M |
| Gross profit | -128.76%-3.16M | -53.53%7.16M | -50.86%11.91M | -9.38%76.61M | -5.05%30.07M | -42.29%10.99M | -13.91%15.41M | 52.12%24.23M | 68.32%84.53M | 39.87%31.66M |
| Operating expense | -412.21%-23.68M | 35.43%9.38M | -1.89%9.94M | 36.77%49.45M | 73.42%23.17M | 34.46%7.59M | -6.14%6.92M | 56.76%10.13M | 39.02%36.16M | 17.86%13.36M |
| Selling and administrative expenses | 114.47%35.23M | 18.22%11.16M | -15.21%11.52M | 36.77%49.45M | 41.49%24.52M | 153.40%16.43M | 22.70%9.44M | 68.54%13.58M | 39.02%36.16M | 98.25%17.33M |
| -Selling and marketing expense | -14.13%3.92M | 378.30%1.63M | -30.09%2.01M | 31.49%14.06M | 24.87%6.28M | 242.28%4.57M | -86.05%341K | 52.44%2.88M | 189.42%10.69M | 465.99%5.03M |
| -General and administrative expense | 163.97%31.31M | 4.73%9.53M | -11.21%9.51M | 38.98%35.39M | 48.28%18.24M | 130.37%11.86M | 73.38%9.1M | 73.46%10.71M | 14.12%25.46M | 56.66%12.3M |
| Total other operating income | 566.22%58.91M | -29.16%1.78M | -54.27%1.58M | 142.96%16.33M | -66.09%1.35M | 950.24%8.84M | 698.10%2.51M | 116.22%3.45M | --6.72M | --3.97M |
| Operating profit | 502.64%20.52M | -126.15%-2.22M | -86.02%1.97M | -43.86%27.16M | -62.33%6.89M | -74.60%3.41M | -19.36%8.48M | 48.95%14.11M | 99.80%48.38M | 61.94%18.3M |
| Net non-operating interest income (expenses) | -96.14%-4.42M | 25.86%-4.58M | 25.59%-4.13M | 7.30%-19.07M | 69.15%-2.99M | 34.74%-2.25M | -43.37%-6.18M | -112.33%-5.55M | -127.03%-20.57M | -303.58%-9.69M |
| Non-operating interest income | 109.30%360K | --57K | --58K | 42.69%732K | 42.69%732K | --172K | --0 | --0 | --513K | --513K |
| Non-operating interest expense | 97.07%4.78M | -24.94%4.64M | -24.54%4.19M | -7.30%19.07M | -63.53%3.72M | -29.76%2.42M | 43.37%6.18M | 112.33%5.55M | 127.03%20.57M | 330.88%10.2M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Special income (charges) | -117.03%-102K | -108.01%-48K | 145.90%599K | 599K | ||||||
| Less:Write off | ---- | ---- | ---- | 117.03%102K | 108.01%48K | ---- | ---- | ---- | -145.90%-599K | ---599K |
| Other non-operating income (expenses) | 80.51%6.91M | -11.06%3.83M | ||||||||
| Income before tax | 1,296.62%16.1M | -394.58%-6.8M | -125.18%-2.16M | -53.78%14.9M | -58.13%3.86M | -88.42%1.15M | -62.86%2.31M | 24.82%8.56M | 77.58%32.24M | -22.57%9.22M |
| Income tax | 20.26%-2.59M | 60.69%-951K | -63.67%908K | -160.17%-4.72M | -184.86%-1.61M | -389.74%-3.25M | -203.55%-2.42M | 0.64%2.5M | 26.04%7.84M | -44.10%1.9M |
| Net income | 324.74%18.69M | -223.68%-5.85M | -150.54%-3.06M | -19.62%19.61M | -25.30%5.47M | -50.17%4.4M | 21.96%4.73M | 38.54%6.06M | 104.43%24.4M | -13.99%7.32M |
| Net income continuous operations | 324.74%18.69M | -223.68%-5.85M | -150.54%-3.06M | -19.62%19.61M | -25.30%5.47M | -50.17%4.4M | 21.96%4.73M | 38.54%6.06M | 104.43%24.4M | -13.99%7.32M |
| Noncontrolling interests | 139.90%652K | -272.14%-1.56M | -1,605.26%-1.43M | -101.43%-1.13M | 824.35%833K | -35.71%-1.63M | -162.22%-420K | 11.76%95K | -156.46%-559K | 80.74%-115K |
| Net income attributable to the company | 198.94%18.04M | -183.21%-4.28M | -127.37%-1.63M | -16.91%20.74M | -37.66%4.63M | -39.87%6.04M | 60.81%5.15M | 39.07%5.97M | 128.03%24.96M | -18.36%7.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 198.94%18.04M | -183.21%-4.28M | -127.37%-1.63M | -16.91%20.74M | -37.66%4.63M | -39.87%6.04M | 60.81%5.15M | 39.07%5.97M | 128.03%24.96M | -18.36%7.43M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 163.64%0.029 | -172.63%-0.0069 | -123.64%-0.0026 | -25.89%0.0375 | -44.08%0.0085 | -40.86%0.011 | 48.44%0.0095 | 18.28%0.011 | 109.96%0.0506 | -23.62%0.0152 |
| Diluted earnings per share | 170.59%0.0276 | -179.31%-0.0069 | -125.74%-0.0026 | -23.70%0.0351 | -42.75%0.0079 | -40.00%0.0102 | 47.46%0.0087 | 31.17%0.0101 | 132.32%0.046 | -15.85%0.0138 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.